Shanghai Pharmaceuticals to Review and Approve Q1 2026 Results on 29 April 2026

Bulletin Express04-17

Shanghai Pharmaceuticals Holding Co., Ltd. announced that its board of directors will convene on Wednesday, 29 April 2026. The primary agenda is to consider and approve the consolidated results of the Company and its subsidiaries for the three months ended 31 March 2026, followed by the release of the first-quarter financial report.

The notice, signed by Chairman Yang Qiuhua in Shanghai on 17 April 2026, also reconfirmed the current board composition: four executive directors (Yang Qiuhua, Shen Bo, Li Yongzhong, Dong Ming), one non-executive director (Zhang Wenxue), one employee director (Zhao Yong), and four independent non-executive directors (Gu Zhaoyang, Fok Manson, Wang Zhong, Man Kwan).

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited stated that they assume no responsibility for the contents of the announcement.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1182605467?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-17 17:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182605467","market":"us","top_or_hot":-1,"title":"Shanghai Pharmaceuticals to Review and Approve Q1 2026 Results on 29 April 2026","media":"Bulletin Express","content":"<p>Shanghai Pharmaceuticals Holding Co., Ltd. announced that its board of directors will convene on Wednesday, 29 April 2026. The primary agenda is to consider and approve the consolidated results of the Company and its subsidiaries for the three months ended 31 March 2026, followed by the release of the first-quarter financial report.</p>\n<p>The notice, signed by Chairman Yang Qiuhua in Shanghai on 17 April 2026, also reconfirmed the current board composition: four executive directors (Yang Qiuhua, Shen Bo, Li Yongzhong, Dong Ming), one non-executive director (Zhang Wenxue), one employee director (Zhao Yong), and four independent non-executive directors (Gu Zhaoyang, Fok Manson, Wang Zhong, Man Kwan).</p>\n<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited stated that they assume no responsibility for the contents of the announcement.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Pharmaceuticals to Review and Approve Q1 2026 Results on 29 April 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Pharmaceuticals to Review and Approve Q1 2026 Results on 29 April 2026\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-17 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Pharmaceuticals Holding Co., Ltd. announced that its board of directors will convene on Wednesday, 29 April 2026. The primary agenda is to consider and approve the consolidated results of the Company and its subsidiaries for the three months ended 31 March 2026, followed by the release of the first-quarter financial report.</p>\n<p>The notice, signed by Chairman Yang Qiuhua in Shanghai on 17 April 2026, also reconfirmed the current board composition: four executive directors (Yang Qiuhua, Shen Bo, Li Yongzhong, Dong Ming), one non-executive director (Zhang Wenxue), one employee director (Zhao Yong), and four independent non-executive directors (Gu Zhaoyang, Fok Manson, Wang Zhong, Man Kwan).</p>\n<p>Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited stated that they assume no responsibility for the contents of the announcement.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02607","symbol_name":"上海医药","start_time":0,"source_url":"","article_id":"1182605467","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182605467","pubTimestamp":1776416724,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Pharmaceuticals Holding Co., Ltd. announced that its board of directors will convene on Wednesday, 29 April 2026. The primary agenda is to consider and approve the consolidated results of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02607":"上海医药"},"translate_title":"上海医药将于2026年4月29日审核及批准2026年第一季度业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02607":1},"content_text":"Shanghai Pharmaceuticals Holding Co., Ltd. announced that its board of directors will convene on Wednesday, 29 April 2026. The primary agenda is to consider and approve the consolidated results of the Company and its subsidiaries for the three months ended 31 March 2026, followed by the release of the first-quarter financial report.\nThe notice, signed by Chairman Yang Qiuhua in Shanghai on 17 April 2026, also reconfirmed the current board composition: four executive directors (Yang Qiuhua, Shen Bo, Li Yongzhong, Dong Ming), one non-executive director (Zhang Wenxue), one employee director (Zhao Yong), and four independent non-executive directors (Gu Zhaoyang, Fok Manson, Wang Zhong, Man Kwan).\nHong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited stated that they assume no responsibility for the contents of the announcement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1182605467","isCrawlerRequest":true}